Philip L Smith Selected Research

Body Weight (Weight, Body)

1/2020	Safety, Pharmacokinetics, and Activity of High-Dose Ivermectin and Chloroquine against the Liver Stage of Plasmodium cynomolgi Infection in Rhesus Macaques.
7/2015	Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics.
10/2013	Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.
9/2011	Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip L Smith Research Topics

Disease

7	Malaria 07/2020 - 04/2005
7	Obstructive Sleep Apnea 05/2017 - 03/2003
6	Sleep Apnea Syndromes (Sleep Apnea) 05/2014 - 03/2002
5	Obesity 05/2012 - 09/2005
4	Infections 01/2020 - 11/2011
4	Body Weight (Weight, Body) 01/2020 - 09/2011
4	Apnea 09/2011 - 11/2006
4	Hypoxia (Hypoxemia) 09/2011 - 10/2003
3	Cutaneous Leishmaniasis 10/2013 - 01/2009
2	Morbid Obesity 01/2016 - 05/2014
2	Insulin Resistance 01/2016 - 10/2003
2	Airway Obstruction (Choking) 05/2014 - 07/2007
2	Inflammation (Inflammations) 01/2014 - 10/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2014 - 01/2010
2	Weight Loss (Weight Reduction) 05/2012 - 09/2011
2	Atherosclerosis 06/2007 - 02/2007
1	COVID-19 01/2020
1	Parasitemia 01/2020
1	Vivax Malaria 10/2019
1	Glucosephosphate Dehydrogenase Deficiency 10/2018
1	Snoring 05/2017
1	Falciparum Malaria (Plasmodium falciparum Malaria) 04/2015
1	Respiratory Insufficiency (Respiratory Failure) 05/2014
1	Fatigue 01/2014
1	Sleepiness 01/2014
1	Necrosis 01/2014
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2014
1	HIV Infections (HIV Infection) 01/2014
1	Visceral Leishmaniasis (Kala Azar) 10/2013
1	Heart Failure 09/2011
1	Neglected Diseases 01/2009
1	Dyslipidemias (Dyslipidemia) 06/2007
1	Hyperglycemia 04/2007
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 11/2006
1	Fatty Liver 11/2005
1	Hyperlipidemias (Hyperlipidemia) 09/2005
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2003
1	Parkinson Disease (Parkinson's Disease) 02/2003

Drug/Important Bio-Agent (IBA)

5	LeptinIBA 05/2014 - 10/2003
4	Pharmaceutical PreparationsIBA 07/2020 - 10/2013
4	Primaquine FDA Link 10/2019 - 07/2015
4	CholesterolIBA 10/2007 - 09/2005
3	Chloroquine (Aralen)FDA LinkGeneric 07/2020 - 04/2015
3	Insulin (Novolin)FDA Link 01/2016 - 10/2003
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 03/2002
3	Oxygen (Dioxygen)IBA 09/2011 - 03/2002
3	LipidsIBA 02/2007 - 09/2005
2	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 10/2013 - 02/2013
2	Gentamicins (Gentamicin)FDA LinkGeneric 10/2013 - 02/2013
1	Genetic Markers (Genetic Marker)IBA 07/2020
1	plasmepsin (plasmepsin I)IBA 07/2020
1	Exonucleases (3' 5' Exonuclease)IBA 07/2020
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2020
1	Ivermectin (Mectizan)FDA Link 01/2020
1	piperaquineIBA 10/2018
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2018
1	Matrix Metalloproteinases (MMPs)IBA 10/2018
1	artenimol (dihydroartemisinin)IBA 10/2018
1	VaccinesIBA 01/2017
1	Antimalarials (Antimalarial Agents)IBA 01/2016
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2016
1	tafenoquineIBA 07/2015
1	Mefloquine (Lariam)FDA LinkGeneric 04/2015
1	InterleukinsIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 09/2011
1	Nonesterified Fatty Acids (NEFA)IBA 09/2011
1	AdiponectinIBA 09/2011
1	GhrelinIBA 09/2011
1	CytokinesIBA 09/2011
1	Interleukin-6 (Interleukin 6)IBA 09/2011
1	Leptin ReceptorsIBA 09/2011
1	Ointments (Pastes)IBA 01/2009
1	AminoglycosidesIBA 01/2009
1	Oxyhemoglobins (Oxyhemoglobin)IBA 07/2007
1	LDL CholesterolIBA 06/2007
1	EnzymesIBA 06/2007
1	Lipoproteins (Lipoprotein)IBA 06/2007
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 06/2007
1	GlycogenIBA 04/2007
1	Triglycerides (Triacylglycerol)IBA 04/2007
1	cycloguanilIBA 04/2005
1	Folic Acid AntagonistsIBA 04/2005
1	Blood Glucose (Blood Sugar)IBA 10/2003
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 02/2003
1	Tolcapone (Tasmar)FDA Link 02/2003

Therapy/Procedure

5	Continuous Positive Airway Pressure 05/2017 - 03/2003
3	Therapeutics 01/2020 - 01/2009
3	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 01/2010
2	Bariatric Surgery 05/2014 - 09/2011
2	Device Removal (Removal, Device) 02/2014 - 11/2011
2	Cannula 07/2009 - 07/2007
1	Traction 02/2010
1	Airway Management 02/2010
1	Tracheostomy 11/2006